Norway· NO-ID_E0979F23-06F7-4DFE-BD76-9C1D7D4AD523
Erbitux
A cetuximab product containing cetuximab, registered in Norway by Merck Europe B.V.. The same ATC class is registered in 12 of our 19 countries.
Checked against FEST (Norway) on
Informational only — not a medical device.
Where it is registered
Cetuximab is registered in 12 of 19 countries.
Countries holding a registration under ATC L01FE01 (cetuximab), each read from that country’s own register.
- This record: Norway, from FEST (Norway)
- 8 of them publish a price we can compare per daily dose
Cetuximab · ATC L01FE01
12 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
FEST (Norway)- Active substance
- Cetuximab
- Manufacturer
- Merck Europe B.V.
- Country
- Norway (NO)
- ATC code
- L01FE01
- ATC class
- Cetuximab
- Defined daily dose
- 65 mg, P
- Reimbursed
- Not published by this register
- Source register
- FEST (Norway)
- Last checked
- October 2, 2026
Packs & prices · 5
2 priced- no_merkevare_idID_E0979F23-06F7-4DFE-BD76-9C1D7D4AD523
- no_varenummer1281261 x 100NOK 11593.4
- no_varenummer3974941 x 20NOK 2347.7
- gtin4054839243776
- gtin4054839243783
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
18 interactions on record for cetuximab.
Graded by severity as the source publishes them — 2 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Cetuximab · interactions on record
18 records
- 2 severe
- 16 moderate
Most severe, free to view
- Aminolevulinic acidL01XD04severe
- ThalidomideL04AX02severe
- OmeprazoleA02BC01moderate
- PantoprazoleA02BC02moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Cetuximab in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandErbituxParanova Oy
- SwitzerlandErbitux
- CzechiaERBITUXMerck Europe B.V., Amsterdam
- BelgiumErbitux 5 mg/mlMerck Europe
- SpainERBITUX 5 MG/ML SOLUCION PARA PERFUSIONMerck Europe B.V.
- IcelandErbituxMerck Europe B.V.*
- PolandErbituxMerck Europe B.V.
- SwedenErbitux 5 mg/ml Infusionsvätska, lösningMerck Europe B.V.
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Iceland · Erbitux
- Liechtenstein · Erbitux
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/591a11c7-d52a-456c-872b-adb28a3ee5bc GET /v1/drugs/591a11c7-d52a-456c-872b-adb28a3ee5bc?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Infusjonsvæske, oppløsning",
"source": "fest",
"status": "A",
"atc_name": "Cetuksimab",
"merkevare_id": "ID_E0979F23-06F7-4DFE-BD76-9C1D7D4AD523",
"name_form_strength": "Erbitux inf, oppl 5 mg/ml",
"prescription_group": "C"
}See everything about cetuximab.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.